Home
Pulmonary Function Testing
Clinical Research
Our Doctors
Contact Us
Physician Referral Form
More
Trial Enrolment Status
OPEN
Disease Under Study
ASTHMA
Duration
~28 Weeks
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
JAK1 Inhibitor
Dr. George Philteos
Dr. Anushya Chelvanathan
Nusrat Jahan